Advertisement

Primary Epithelial Malignancies

  • Yener S. Erozan
  • Ibrahim Ramzy
Chapter
  • 1.1k Downloads
Part of the Essentials in Cytopathology book series (EICP, volume 15)

Abstract

This chapter has been updated according to the newly proposed classification of lung carcinomas and its application to small biopsies and cytology specimens which provides uniform terminology and criteria for diagnosing subtypes of lung carcinomas, specifically adenocarcinomas and poorly differentiated carcinomas.

Cytopathologic features of squamous cell carcinomas and pre-squamous lesions, adenocarcinomas, large cell carcinoma, small cell carcinoma, neuroendocrine neoplasms, and salivary gland-like tumors are presented, and their differential diagnoses are discussed.

Keywords

Carcinoid Tumor Small Cell Carcinoma Adenoid Cystic Carcinoma Merkel Cell Carcinoma Tissue Fragment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

Classification of Lung Tumors

  1. Travis WD, Brambilla E, Muller-Hermelink HK, et al., editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004.Google Scholar
  2. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244–85.PubMedCrossRefGoogle Scholar
  3. Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of lung cancer in small biopsies and cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med. 2013a;37:668–84.CrossRefGoogle Scholar
  4. Travis WD, Rekhtman N. Pathological diagnosis and classification of lung cancer in small biopsies and cytology: Strategic management of tissue for molecular testing. Semin Respir Crit Care Med. 2011;32:22–31.PubMedCrossRefGoogle Scholar
  5. Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of lung adenocarcinoma in resected specimens. Arch Pathol Lab Med. 2012;136:1–23.Google Scholar
  6. Travis WD, Brambilla E, Riely GJ. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. J Clin Oncol. 2013b;31:992–1001.PubMedCrossRefGoogle Scholar

Pre-invasive Lesions

  1. Baba M, Iyoda A, Nomoto Y, et al. Cytological findings of pre-invasive bronchial lesions detected by light-induced fluorescence endoscopy in a lung cancer screening system. Oncol Rep. 2007;17:579–83.PubMedGoogle Scholar
  2. Dacic S. Pulmonary preneoplasia. Arch Pathol Lab Med. 2008a;132:1073–8. Review.PubMedGoogle Scholar
  3. Kennedy TC, McWilliams A, Edell E, et al. American College of Chest Physicians: Bronchial intraepithelial neoplasia/early central airways lung cancer. ACCP evidence- based clinical practice guidelines (2nd ed). Chest. 2007;132:211S–2333S.Google Scholar
  4. Marek W, Richartz G, Philippou S, et al. Sputum screening for lung cancer in random exposed uranium miners: a comparison of semi-automated sputum cytometry and conventional cytology. J Physiol Pharmacol. 2007;58(Suppl 5(Pt 1)):349–61.PubMedGoogle Scholar
  5. Shibuya K, Fujisawa T, Hoshino H, et al. Fluorescence bronchoscopy in the detection of preinvasive bronchial lesions in patients with sputum cytology suspicious or positive for malignancy. Lung Cancer. 2001;32:19–25.PubMedCrossRefGoogle Scholar

Small Cell Carcinoma

  1. Leech SN, Kolar AJ, Barrett PD, et al. Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor-1. J Clin Pathol. 2001;54:727–9.PubMedCentralPubMedCrossRefGoogle Scholar
  2. Ordonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol. 2000;24:1217–23.PubMedCrossRefGoogle Scholar
  3. Yang YJ, Steele CT, Ou XL, et al. Diagnosis of high-grade pulmonary neuroendocrine carcinoma by fine-needle aspiration biopsy: nonsmall-cell or small-cell type. Diagn Cytopathol. 2001;25:292–300.PubMedCrossRefGoogle Scholar
  4. Zhang H, Liu J, Cagle PT, et al. Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach. Mod Pathol. 2005;18:111–8.PubMedCrossRefGoogle Scholar

Subtyping of Non-Small Cell Carcinomas

  1. Sigel CS, Moreira AL, Travis WD, et al. Subtyping of non-small cell carcinoma: a comparison of small biopsy and cytology specimens. J Thorac Oncol. 2011;11:1849–56.CrossRefGoogle Scholar
  2. Tourney KG, Carprieaux M, Deschepper E, et al. Are EUS-FNA and EBUS-TBNA specimens reliable for subtyping non-small cell lung cancer? Lung Cancer. 2012;76:46–50.CrossRefGoogle Scholar
  3. Pelosi G, Fabbri A, Bianchi F, et al. DN63 (p 40) and thyroid transcription factor-1 immunoreactivity in small biopsies or cell blocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach. J Thorac Oncol. 2012;7:281–90.PubMedCrossRefGoogle Scholar
  4. Rekhtman N, Ang DC, Sima CS, et al. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole tissue sections with validation in small specimens. Mod Pathol. 2011;10:1348–59.CrossRefGoogle Scholar

Papillary and Micropapillary Adenocarcinoma

  1. Duncan LD, Jacob S, Atkinson S. Fine needle aspiration findings of micropapillary carcinoma in the lung. A case report. Acta Cytol. 2007;51:605–8.PubMedCrossRefGoogle Scholar
  2. Hoshi R, Tsuzuku M, Horai T, et al. Micropapillary clusters in early-stage lung adenocarcinomas: a distinct cytologic sign of significantly poor prognosis. Cancer. 2004;102:81–6.PubMedCrossRefGoogle Scholar
  3. Myoshi T, Satoh Y, Okumura S, et al. Early stage lung adenocarcinomas with micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol. 2003;27:101–9.CrossRefGoogle Scholar

Neuroendocrine Tumors: Carcinoid

  1. Nicholson SA, Ryan MR. A review of cytologic findings in neuroendocrine carcinomas including carcinoid tumors with histologic correlations. Cancer Cytopathol. 2000;90:148–61.CrossRefGoogle Scholar
  2. Stoll LM, Johnson MW, Burroughs F, et al. Cytologic diagnosis and differential diagnosis of lung carcinoid tumors: A retrospective study of 63 cases with histologic correlation. Cancer (Cancer Cytopathol). 2010;118:457–67.CrossRefGoogle Scholar
  3. Thiryayi SA, Rana DN, Perera DM. Bronchial carcinoid tumor: Cytologic features on ThinPrep and a diagnostic pitfall in bronchial brushings and washings. Diagn Cytopathol. 2008;36:275–6.PubMedCrossRefGoogle Scholar
  4. Sica G, Vazquez MF, Altorki N, et al. PAX-5 expression in pulmonary neuroendocrine neoplasms: Its usefulness in surgical and fine-needle aspiration biopsy specimens. Am J Clin Pathol. 2008;129:556–62.PubMedCrossRefGoogle Scholar
  5. Renshow AA, Haja J, Lozano RL, et al. Cytology Committee, College of American Pathologists. Distinguishing carcinoid tumor from small cell carcinoma of the lung: Correlating cytologic features and performance in the College of American Pathologists Non-gynecologic Cytology Program. Arch Pathol Lab Med. 2005;129:614–8.Google Scholar

Neuroendocrine Tumors: Large Cell Neuroendocrine Carcinoma

  1. Hiroshima K, Abe S, Ebihara Y, et al. Cytological characteristics of pulmonary large cell neuroendocrine carcinoma. Lung Cancer. 2005;48:331–7.PubMedCrossRefGoogle Scholar
  2. Hiroshima K, Iyoda A, Shida T, et al. Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis. Mod Pathol. 2006;19:1358–68.PubMedCrossRefGoogle Scholar
  3. Hoshi R, Furuta N, Horai T, et al. Discriminent model for cytologic distinction for large cell neuroendocrine carcinoma from small cell carcinoma of the lung. J Thorac Oncol. 2010;5:472–8.PubMedCrossRefGoogle Scholar
  4. Kakinuma H, Mikami T, Iwabuchi K, et al. Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas: comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas. Cancer. 2003;99:247–54.PubMedCrossRefGoogle Scholar
  5. Wiatrowska BA, Krol J, Zakowski MF. Large-cell neuroendocrine carcinoma of the lung: proposed criteria for cytologic diagnosis. Diagn Cytopathol. 2001;24:58–64.PubMedCrossRefGoogle Scholar
  6. Maleki Z. Diagnostic issues with cytopathologic interpretation of lung neoplasms displaying high-grade basaloid or neuroendocrine morphology. Diagn Cytopathol. 2011;39:159–67.PubMedCrossRefGoogle Scholar
  7. Franks TJ, Galvin JR. Lung tumors with neuroendocrine morphology: essential radiologic and pathologic features. Arch Pathol Lab Med. 2008;132(7):1055–61. Review.PubMedGoogle Scholar

Salivary Gland Type Tumors

  1. Daneshbod Y, Modjtahedi E, Atefi S, et al. Exfoliative cytologic findings of primary pulmonary adenoid cystic carcinoma. A report of 2 cases with a review of the cytologic features. Acta Cytol. 2007;51:558–62.PubMedCrossRefGoogle Scholar
  2. Monaco SE, Khalbuss WE, Ustinova E, et al. The cytomorphologic spectrum of salivary gland type tumors in the lung and Mediastinum: A report of 16 patients. Diagn Cytopathol. 2012;40:1062–70.PubMedCrossRefGoogle Scholar

Differential Diagnosis and Pitfalls

  1. Cagle PT, Kovach M, Ramzy I. Causes of false results in transthoracic fine needle lung aspirates. Acta Cytol. 1993;37:16–20.PubMedGoogle Scholar
  2. Hughes JH, Young NA, Wilbur DC, et al. Cytopathology Resource Committee, College of American Pathologists: Fine-needle aspiration of pulmonary hamartoma: a common source of false-positive diagnosis in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med. 2005;129:19–22.PubMedGoogle Scholar
  3. Idowu MO, Powers CN. Lung cancer cytology: potential pitfalls and mimics - a review. Int J Clin Exp Pathol. 2010;3:367–85.PubMedCentralPubMedGoogle Scholar
  4. Naryshkin S, Young NA. Respiratory cytology: A review of non-neoplastic mimics of malignancy. Diagn Cytopathol. 1993;9:89–97.PubMedCrossRefGoogle Scholar
  5. Policarpio-Nicolas MLC, Wick MR. False-positive interpretations in respiratory cytopathology: Exemplary cases and literature review. Diagn Cytopathol. 2008;36:13–9.PubMedCrossRefGoogle Scholar
  6. Saad RS, Silverman JF. Respiratory cytology: Differential diagnosis and pitfalls. Diagn Cytopathol. 2010;38:297–307.PubMedGoogle Scholar
  7. Zaman SS, van Hoeven KH, Slott S, et al. Distinction between bronchioloalveolar carcinoma and hyperplastic pulmonary proliferations: a cytologic and morphometric analysis. Diagn Cytopathol. 1997;16:396–401.PubMedCrossRefGoogle Scholar

Immunohistochemistry

  1. Al-Haddad M, Wallace MB. EUS-FNA and biomarkers for the staging of non-small cell lung cancer. Endoscopy. 2006;38:114–7.CrossRefGoogle Scholar
  2. Beasley MB. Immunohistochemistry of pulmonary and pleural neoplasia. Arch Pathol Lab Med. 2008;132:1062–72. Review.PubMedGoogle Scholar
  3. Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 in carcinoma of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol. 2010;41:20–5.PubMedCrossRefGoogle Scholar
  4. Bishop JA, Teruya-Feldstein J, Westra WH, et al. p40(DNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol. 2012;25:405–15.PubMedCrossRefGoogle Scholar
  5. Dabbs DJ. Diagnostic immunohistochemistry, ed 4. Philadelphia, PA: Elsevier-Saunders; 2014.Google Scholar
  6. Jagirdar J. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma of lung. Arch Pathol Lab Med. 2008;132:384–96.PubMedGoogle Scholar
  7. Ocque R, Tochigi N, Ohori NP, et al. Usefulness of immunohistochemical and histochemical stains in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens. Am J Clin Pathol. 2011;136:81–7.PubMedCrossRefGoogle Scholar
  8. Hirano T, Gong Y, Yoshida K, et al. Usefulness of TA02 (Napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma. Lung Cancer. 2003;41:155–62.PubMedCrossRefGoogle Scholar

Molecular Studies

  1. Dacic S. EGFR assays in lung cancer. Adv Anat Pathol. 2008b;15:241–7. Review.PubMedCrossRefGoogle Scholar
  2. Ikeda K, Nomori H, Ohba Y, et al. Epidermal growth factor receptor in multicentric lung adenocarcinomas and atypical adenomatous hyperplasias. J Thorac Oncol. 2008;3:467–71.PubMedCrossRefGoogle Scholar
  3. Katz RL, Zaidi TM, Fernandez RL, et al. Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer. Mod Pathol. 2008;21:1065.CrossRefGoogle Scholar
  4. Lindeman NI, Cagle PT, Beasley MB, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK1 myosin kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med. 2013;137:828–60.PubMedCrossRefGoogle Scholar
  5. Sakairi Y, Nakajima T, Yasufuku K, et al. EML4-ALK fusion gene assessment using metastatic node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration. Clin Cancer Res. 2010;16:4938–45.PubMedCrossRefGoogle Scholar
  6. Takahashi T, Sonobe M, Kobayashi M, et al. Clinicopathologic features of non-small cell lung cancer with EML4-ALK fusion gene. Ann Surg Oncol. 2010;17:889–97.PubMedCrossRefGoogle Scholar

Other

  1. Alasio TM, Sun W, Yang GC. Giant cell carcinoma of the lung impact of diagnosis and review of cytologic features. Diagn Cytopathol. 2007;35:555–9.PubMedCrossRefGoogle Scholar
  2. Auger M, Katz RL, Johnston DA. Differentiating cytologic features of bronchioloalveolar carcinoma from adenocarcinoma of the lung in fine-needle aspiration: a statistical analysis of 27 cases. Diagn Cytopathol. 1997;16:253–7.PubMedCrossRefGoogle Scholar
  3. Erozan YS, Yang GLH. Squamous, large cell and sarcomatoid carcinomas. Chapter 6 in lung and mediastinum cytohistology. Ali SZ, Yang GC, editors. Cambridge University Press, Cambridge, 2012.Google Scholar
  4. Hasanovic A, Rekhtman N, Sigel CS, et al. Advances in fine needle aspiration cytology for the diagnosis of pulmonary carcinoma. Pathol Res Inter. 2011;2011:1–7.CrossRefGoogle Scholar
  5. Crapanzano JP, Loukeris K, Borczuk AC, et al. Cytological, histological, and immunohistochemical findings of pulmonary carcinomas with basaloid features. Diagn Cytopathol. 2011;39:92–100.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Yener S. Erozan
    • 1
  • Ibrahim Ramzy
    • 2
    • 3
  1. 1.Department of PathologyThe Johns Hopkins School of MedicineBaltimoreUSA
  2. 2.Departments of Pathology - Laboratory Medicine & of Obstetrics-GynecologyUniversity of CaliforniaIrvineUSA
  3. 3.Department of PathologyBaylor College of MedicineHoustonUSA

Personalised recommendations